ReviewPharmaceutics2024

The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems.

Nargish Parvin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.